公式財務諸表に基づく売上高、利益、キャッシュフローの推移。
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth.
インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→
| 損益計算書 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高合計 | $4.1B | $4.0B | $4.0B | $3.9B | $3.7B | $4.0B | $2.5B | $2.4B | $2.0B | $1.5B | $1.1B | $845M | $762M | $660M | $560M | $480M | $387M | $312M | $304M | $284M | $206M |
| 売上総利益 | $2.8B | $2.8B | $2.8B | $2.7B | $2.6B | $2.9B | $1.8B | $1.7B | $1.4B | $1.1B | $815M | $640M | $578M | $498M | $416M | $361M | $303M | $233M | $225M | $209M | $142M |
| 売上総利益率 % | 68.1% | 68.3% | 70.0% | 70.1% | 70.5% | 74.3% | 71.3% | 72.5% | 73.6% | 75.8% | 75.5% | 75.7% | 75.9% | 75.4% | 74.4% | 75.3% | 78.4% | 74.8% | 74.1% | 73.6% | 68.6% |
| 営業利益（EBIT） | $622M | $616M | $608M | $643M | $643M | $976M | $387M | $542M | $467M | $354M | $249M | $189M | $194M | $94M | $86M | $90M | $103M | ($34M) | $16M | $34M | ($38M) |
| 営業利益率 % | 15.0% | 15.3% | 15.2% | 16.7% | 17.2% | 24.7% | 15.7% | 22.5% | 23.7% | 24.0% | 23.1% | 22.3% | 25.4% | 14.3% | 15.3% | 18.8% | 26.5% | -10.9% | 5.1% | 11.9% | -18.2% |
| 当期純利益 | $414M | $410M | $421M | $445M | $362M | $772M | $1.8B | $443M | $400M | $231M | $190M | $144M | $146M | $64M | $59M | $67M | $74M | ($31M) | $80M | $36M | ($35M) |
| 純利益率 % | 10.0% | 10.2% | 10.5% | 11.5% | 9.7% | 19.5% | 71.8% | 18.4% | 20.3% | 15.7% | 17.6% | 17.0% | 19.1% | 9.7% | 10.5% | 13.9% | 19.2% | -10.0% | 26.3% | 12.6% | -16.9% |
| EBITDA | — | $766M | $817M | $643M | $780M | $1.1B | $481M | $593M | $521M | $391M | $273M | $207M | $211M | $178M | $140M | $108M | $121M | ($21M) | $30M | $47M | ($27M) |
| 1株当たり利益（EPS） | $5.75 | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 | $0.78 | $0.71 | $0.83 | $0.95 | $-0.45 | $1.18 | $0.50 | $-0.55 |
| 発行済株式数（百万株） | — | 73M | 75M | 77M | 78M | 80M | 79M | 80M | 81M | 82M | 81M | 82M | 82M | 83M | 83M | 80M | 78M | 69M | 68M | 71M | 63M |
出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。
貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は ALGN のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/ALGN
本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。
About TickerBase · Data methodology & sources · Privacy · Terms